International guidelines on stage III N2 nonsmall cell lung cancer: surgery or radiotherapy?
Stage III N2 nonsmall cell lung cancer (NSCLC) is a complex disease with poor treatment outcomes. For patients in whom the disease is considered technically resectable, the main treatment options include surgery (with neoadjuvant or adjuvant chemotherapy/neoadjuvant chemoradiotherapy (CRT)) or CRT f...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2020-02-01
|
| Series: | ERJ Open Research |
| Online Access: | http://openres.ersjournals.com/content/6/1/00159-2019.full |